CompanyGraph
At a glance
- Depends onMidstream position: 6 outgoing, 8 incoming connections
- ScaleMarket cap is $26.28B, higher than 95% of all stocks globally
- FinancialsAltman Z-Score 1.98: grey zone
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
3.66%Above 5Y avg (2.59%)
Annual Rate
EUR 0.85Paid unknown
Payout Ratio
74.6%Moderate
Payback Period
25.4 yr
Last Ex-Dividend
May 12, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
22.56BEUR26.28B · vs all stocks (USD)
Trailing P/E
20.25xRevenue (TTM)
17.66BEUR20.58B · vs all stocks (USD)
Profit Margin
6.31%Beta
0.9100xvs all stocks
52-Week Change
-2.29%vs all stocks
Forward Annual Dividend Yield
3.66%vs all stocks
Market Capitalization
22.56BEUR26.28B · vs all stocks (USD)
Enterprise Value
28.26BEUR32.93B · vs all stocks (USD)
Trailing P/E
20.25xForward P/E
13.71xPEG Ratio
0.3374xPrice to Sales (TTM)
1.28xPrice to Book (MRQ)
1.97xEnterprise to Revenue
1.60xEnterprise to EBITDA
11.70xGross Margin
49.31%Profit Margin
6.31%Operating Margin
13.99%Return on Assets (TTM)
4.07%Return on Equity (TTM)
10.15%Revenue (TTM)
17.66BEUR20.58B · vs all stocks (USD)
Revenue per Share (TTM)
18.55EURUpdated Aug 29, 2026Quarterly Revenue Growth
0.50%Gross Profit (TTM)
8.11BEUR9.45B · vs all stocks (USD)
EBITDA (TTM)
3.02BEUR3.51B · vs all stocks (USD)
Net Income (TTM)
1.11BEUR1.29B · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
60.00%Operating Cash Flow (TTM)
2.28BEUR2.66B · vs all stocks (USD)
Levered Free Cash Flow (TTM)
1.53BEUR1.78B · vs all stocks (USD)
Forward Annual Dividend Rate
0.8500EURUpdated Aug 29, 2026Forward Annual Dividend Yield
3.66%vs all stocks
Trailing Annual Dividend Rate
0.8500EURUpdated Aug 29, 2026Trailing Annual Dividend Yield
3.66%vs all stocks
5-Year Average Dividend Yield
2.59%vs all stocks
Payout Ratio
74.56%Minority Interest (Equity)
32.00MEURFY2025 · Dec 31, 2025Revenue
17.83BEURFY2025 · Dec 31, 2025Cost of Goods Sold
9.78BEURFY2025 · Dec 31, 2025Gross Profit
8.06BEURFY2025 · Dec 31, 2025Operating Income
1.45BEUR1.69B · vs all stocks (USD)
Pre-tax Income
1.18BEURFY2025 · Dec 31, 2025Income Tax Expense
282.00MEURFY2025 · Dec 31, 2025Net Income
897.00MEURFY2025 · Dec 31, 2025EBIT
1.48BEURFY2025 · Dec 31, 2025EBITDA (Income Statement)
2.64BEURFY2025 · Dec 31, 2025Research & Development
1.70BEURFY2025 · Dec 31, 2025Selling, General & Administrative
4.97BEURFY2025 · Dec 31, 2025Other Operating Expenses
-61.00MEURFY2025 · Dec 31, 2025Non-operating Interest Income
83.00MEURFY2025 · Dec 31, 2025Non-operating Interest Expense
294.00MEURFY2025 · Dec 31, 2025EPS (Basic)
0.9400EURFY2025 · Dec 31, 2025EPS (Diluted)
0.9300EURFY2025 · Dec 31, 2025Basic Shares Outstanding
948.24MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
948.24MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
901.00MEURFY2025 · Dec 31, 2025Minority Interests (P&L)
-1.00MEURFY2025 · Dec 31, 2025Operating Cash Flow
1.51BEURFY2025 · Dec 31, 2025Free Cash Flow
1.50BEURDerived from operating cash flow minus capital expenditure. This filing charges 1.12B of depreciation against 9M of capital expenditure, and its own free-cash-flow line reads 504M.FY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
2.79BEURFY2025 · Dec 31, 2025Starting Profit (CF Statement)
901.00MEURFY2025 · Dec 31, 2025Depreciation & Amortization
1.12BEURFY2025 · Dec 31, 2025Deferred Taxes (CF)
282.00MEURFY2025 · Dec 31, 2025Stock-based Compensation
141.00MEURFY2025 · Dec 31, 2025Other Non-cash Items
294.00MEURFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-53.00MEURFY2025 · Dec 31, 2025Change in Accounts Payable (CF)
97.00MEURFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-1.28BEURFY2025 · Dec 31, 2025Capital Expenditures
9.00MEURFY2025 · Dec 31, 2025Net Intangibles (CF)
-136.00MEURFY2025 · Dec 31, 2025Net Acquisitions
-25.00MEURFY2025 · Dec 31, 2025Purchase of Investments
-113.00MEURFY2025 · Dec 31, 2025Sale of Investments
61.00MEURFY2025 · Dec 31, 2025Other Investing Activity
-1.00MEURFY2025 · Dec 31, 2025Net Investing Cash Flow
-69.00MEURFY2025 · Dec 31, 2025Long-term Debt Issuance
1.06BEURFY2025 · Dec 31, 2025Long-term Debt Payments
-609.00MEURFY2025 · Dec 31, 2025Net Short-term Debt Issuance
-24.00MEURFY2025 · Dec 31, 2025Common Stock Repurchase
0.00EURFY2025 · Dec 31, 2025Common Dividends Paid
-328.00MEURFY2025 · Dec 31, 2025Other Financing Charges
-2.00MEURFY2025 · Dec 31, 2025Net Financing Cash Flow
107.00MEURFY2025 · Dec 31, 2025Shares Outstanding
977.43MSharesUpdated Aug 29, 2026Float Shares
976.62MSharesUpdated Aug 29, 2026% Held by Insiders
18.98%vs all stocks
% Held by Institutions
47.53%vs all stocks
Total Cash (MRQ)
1.79BEUR2.08B · vs all stocks (USD)
Total Cash per Share (MRQ)
1.83EURUpdated Aug 29, 2026Total Debt (MRQ)
7.46BEUR8.70B · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.6505xCurrent Ratio (MRQ)
1.26xBook Value per Share (MRQ)
11.71EURUpdated Aug 29, 2026Total Assets
26.94BEUR31.39B · vs all stocks (USD)
Total Current Assets
9.93BEURFY2025 · Dec 31, 2025Total Liabilities
15.96BEURFY2025 · Dec 31, 2025Total Non-current Assets
17.01BEURFY2025 · Dec 31, 2025Total Non-current Liabilities
8.44BEURFY2025 · Dec 31, 2025Total Current Liabilities
7.51BEURFY2025 · Dec 31, 2025Cash
708.00MEURFY2025 · Dec 31, 2025Cash Equivalents
2.09BEURFY2025 · Dec 31, 2025Cash & Cash Equivalents
2.79BEURFY2025 · Dec 31, 2025Accounts Receivable
3.34BEURFY2025 · Dec 31, 2025Inventory
2.87BEURFY2025 · Dec 31, 2025Accounts Payable
1.93BEURFY2025 · Dec 31, 2025Short-term Debt
1.00BEURFY2025 · Dec 31, 2025Deferred Revenue
1.49BEURFY2025 · Dec 31, 2025Other Current Liabilities
321.00MEURFY2025 · Dec 31, 2025Long-term Debt
6.81BEURFY2025 · Dec 31, 2025Other Non-current Liabilities
44.00MEURFY2025 · Dec 31, 2025Common Stock (Book)
193.00MEURFY2025 · Dec 31, 2025Retained Earnings
3.58BEURFY2025 · Dec 31, 2025Total Shareholders' Equity
10.99BEUR12.80B · vs all stocks (USD)
Treasury Stock
298.00MEURFY2025 · Dec 31, 202552-Week Low
20.90EURUpdated Aug 29, 202652-Week High
27.70EURUpdated Aug 29, 202652-Week Change
-2.29%vs all stocks
Beta
0.9100xvs all stocks
50-Day MA
23.52EURUpdated Aug 29, 2026200-Day MA
23.85EURUpdated Aug 29, 2026Avg 10-Day Volume
1.11MSharesUpdated Aug 29, 2026Avg 30-Day Volume
1.72MSharesUpdated Aug 29, 2026Diluted EPS (TTM)
1.14EURUpdated Aug 29, 2026Other Income / Expense
-50.00MEURFY2025 · Dec 31, 20251 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company use capital?
Cash-Backed Earnings Configuration
More cash comes in than it reports as profit, little goes back out on equipment, and much of the gap is depreciation.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.49Profit Margin: 0.06
Financial Health
Altman Z-Score 1.98: grey zoneSignificant
Altman Z-Score: 1.98
Supply Chain
Midstream position: 6 outgoing, 8 incoming connectionsNotable
Outgoing: 6.00Incoming: 8.00
High connectivity hub: 14 industry connectionsNotable
Total Connections: 14.00
Scale
Market cap is $26.28B, higher than 95% of all stocks globallySignificant
Market cap (USD): 26,281,490,942.006Global P95: 26,266,743,019.727
Revenue is $20.58B, higher than 95% of all stocks globallySignificant
Revenue (USD): 20,579,900,978.954Global P95: 15,102,391,082.578
Levered free cash flow is $1.78B, higher than 95% of all stocks globallySignificant
Levered free cash flow (USD): 1,779,552,812.28Global P95: 1,235,239,084.501
Companies that share the same coordination system — how they create, deliver, or capture value.
Incyte Corporation
Tier 1ProductionApproval-Gated PipelineRule
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Roivant Sciences Ltd
Tier 1ProductionApproval-Gated PipelineRuleRisk
Insmed Inc.
Tier 1ProductionApproval-Gated PipelineRule
Steris plc
Tier 1ProductionApproval-Gated PipelineRuleFlow
Hansoh Pharmaceutical Group Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
United Therapeutics Corporation
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Celltrion Inc.
Tier 1ProductionApproval-Gated PipelineRule
Zoetis Inc.
Tier 1ProductionApproval-Gated PipelineRule
Alnylam Pharmaceuticals Inc.
Tier 1ProductionApproval-Gated PipelineRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Papa John's International, Inc.
1 interpretationCash-Backed Earnings Configuration
Quad Graphics Inc.
1 interpretationCash-Backed Earnings Configuration
Ryder System Inc.
1 interpretationCash-Backed Earnings Configuration